Key Takeaways
- Union Minister Dr. Jitendra Singh inaugurated the SAMARTH Skill Development Centre and iDeaNA Technology Incubator in Hyderabad.
- The SAMARTH Centre aims to train a workforce in forensic DNA profiling and molecular diagnostics, while the iDeaNA Incubator supports deep-tech startups.
- These initiatives align with India’s BioE3 Policy to enhance biotechnology integration into the economy and expedite affordable therapies for rare diseases.
New Initiatives Launched to Strengthen Biotechnology in India
Dr. Jitendra Singh, Union Minister, has inaugurated two significant initiatives at the Centre for DNA Fingerprinting and Diagnostics (CDFD) in Hyderabad: the SAMARTH Skill Development Centre and the iDeaNA Technology Incubator.
The SAMARTH Centre (Skilling and Accessing Molecular Advancements in Research and Technology for Health) is designed to address gaps in forensic DNA profiling and molecular diagnostics. It aims to provide certified training to develop an industry-ready workforce that can enhance domestic medical technologies.
Meanwhile, the iDeaNA Incubator is emerging as a vital platform for deep-tech startups. Since its establishment, the incubator has onboarded 12 startups, created over 30 high-skilled jobs, and facilitated funding totalling Rs 15 crore. It has also helped develop five market-ready products.
In addition to inaugurating these initiatives, Dr. Singh led a brainstorming session on ‘Bench to Bedside’ solutions focused on rare disorders. The session emphasized the importance of translating laboratory research into cost-effective therapies. Startups participating in this discussion presented various innovative solutions, including gut-healing sweeteners and advanced biomaterials aimed at skincare.
These initiatives are significant components of India’s BioE3 Policy, which aims to unify biotechnology efforts with economic and environmental goals. This policy is designed to promote high-performance biomanufacturing, facilitating the translation of scientific discoveries into practical treatments. The focus is on ensuring that breakthroughs from laboratories reach patients in the form of affordable therapies for rare diseases.
The launch of the SAMARTH Centre and iDeaNA Incubator signifies a robust step towards advancing India’s capabilities in biotechnology, enhancing workforce skills, and supporting innovative startups within the sector.
The content above is a summary. For more details, see the source article.